This protocol is judged by an institutional overview board, an impartial group that testimonials any medical trials involving individuals. If a review includes a Schedule I drug, as soon as the board approves the protocol as moral, the scientists must submit an application for an investigational new drug (IND) quantity within the FDA.While the pro